Tejal Patel1, Karen Slonim1, Linda Lee1. 1. School of Pharmacy (Patel), University of Waterloo; The Centre for Family Medicine Family Health Team (Patel, Slonim, Lee), Kitchener; and the Department of Family Medicine (Lee), McMaster University, Hamilton, Ontario.
Abstract
BACKGROUND: Older adults with dementia are at high risk for drug-related adverse outcomes. While much is known about potentially inappropriate medication use in older adults, its prevalence and characteristics among those with dementia are not as well elucidated. We conducted a literature review to examine the prevalence of potentially inappropriate medication use among home-dwelling older adults with dementia. Our secondary aim was to determine the most frequently implicated medications and factors associated with potentially inappropriate medication use. METHODS: MEDLINE, EMBASE, CINAHL, and International Pharmaceutical Abstracts were searched between 1946 and 2014 for articles that referenced potentially inappropriate medication use and types of dementia. One reviewer screened all titles and abstracts from the initial search and full-text articles after the initial screen for eligibility, then 2 reviewers independently abstracted data from included studies. RESULTS: Searches yielded 81 articles, of which 7 met inclusion criteria. Prevalence of potentially inappropriate medication use varied from 15% to 46.8%. No single drug or drug class was reported consistently across all studies as the most frequent potentially inappropriate medication, but anticholinergics and benzodiazepines, drugs that affect cognition, were among the most common medications or pharmacological classes listed. DISCUSSION: Older adults with dementia may be particularly vulnerable to potentially inappropriate medications because of cognitive impairment from their condition and the greater likelihood of experiencing adverse events from medications. Given this population's greater susceptibility to adverse events, more intense medication and patient monitoring may be warranted, especially among those taking anticholinergics and benzodiazepines, as these drugs can contribute to cognitive impairment.
BACKGROUND: Older adults with dementia are at high risk for drug-related adverse outcomes. While much is known about potentially inappropriate medication use in older adults, its prevalence and characteristics among those with dementia are not as well elucidated. We conducted a literature review to examine the prevalence of potentially inappropriate medication use among home-dwelling older adults with dementia. Our secondary aim was to determine the most frequently implicated medications and factors associated with potentially inappropriate medication use. METHODS: MEDLINE, EMBASE, CINAHL, and International Pharmaceutical Abstracts were searched between 1946 and 2014 for articles that referenced potentially inappropriate medication use and types of dementia. One reviewer screened all titles and abstracts from the initial search and full-text articles after the initial screen for eligibility, then 2 reviewers independently abstracted data from included studies. RESULTS: Searches yielded 81 articles, of which 7 met inclusion criteria. Prevalence of potentially inappropriate medication use varied from 15% to 46.8%. No single drug or drug class was reported consistently across all studies as the most frequent potentially inappropriate medication, but anticholinergics and benzodiazepines, drugs that affect cognition, were among the most common medications or pharmacological classes listed. DISCUSSION: Older adults with dementia may be particularly vulnerable to potentially inappropriate medications because of cognitive impairment from their condition and the greater likelihood of experiencing adverse events from medications. Given this population's greater susceptibility to adverse events, more intense medication and patient monitoring may be warranted, especially among those taking anticholinergics and benzodiazepines, as these drugs can contribute to cognitive impairment.
Authors: Thomas Fiss; Jochen René Thyrian; Konstanze Fendrich; Neeltje van den Berg; Wolfgang Hoffmann Journal: Int J Geriatr Psychiatry Date: 2012-04-16 Impact factor: 3.485
Authors: Dedan Opondo; Saied Eslami; Stefan Visscher; Sophia E de Rooij; Robert Verheij; Joke C Korevaar; Ameen Abu-Hanna Journal: PLoS One Date: 2012-08-22 Impact factor: 3.240
Authors: Philipp Hessmann; Jan Zeidler; Jona Stahmeyer; Sveja Eberhard; Jonathan Vogelgsang; Mona Abdel-Hamid; Claus Wolff-Menzler; Jens Wiltfang; Bernhard Kis Journal: Front Pharmacol Date: 2019-07-24 Impact factor: 5.810
Authors: Natacha Christina de Araújo; Erika Aparecida Silveira; Brenda Godoi Mota; João Paulo Neves Mota; Ana Elisa Bauer de Camargo Silva; Rafael Alves Guimarães; Valéria Pagotto Journal: PLoS One Date: 2020-10-28 Impact factor: 3.240